GSK plc
Big Pharma race to snap up biotech assets as $170 billion patent cliff looms
Two employees in pharmaceutical industry wearing protective gloves, mask, cap and white suit seen standing by the machine that is the part of the medicaments production during the working hours in a pharmaceutical manufacturing. Extreme-photographer | E+ | Getty Images A multitude of factors are coming together to bring a big burst in biotech M&A. […]
Read More
CNBC’s UK Exchange newsletter: Is Britain back? Five things to watch for the U.K. in 2026
This report is from this week’s CNBC’s UK Exchange newsletter. Like what you see? You can subscribe here. The dispatch A new year brings with it optimism for the coming 12 months The main hope for the U.K. must be that 2026 proves to be better — for the economy, households and individual businesses — than […]
Read More
Nine of the largest pharma companies ink deals with Trump to lower drug prices
President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]
Read More
This is how exposed European Big Pharma is to the U.S.
Novo Nordisk CEO Maziar Mike Doustdar shakes hands with U.S. President Donald Trump during an event to announce a deal with Eli Lilly and Novo Nordisk to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White House in Washington, D.C., U.S., November 6, 2025. Jonathan Ernst | […]
Read More
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Drug pricing has emerged as a key topic to watch for pharmaceutical companies and investors in 2025. As President Donald Trump pushes for lower medicine prices for Americans, the sector is facing additional pricing pressure from a Biden-era law called the Inflation Reduction Act. The IRA, voted into law in 2022, allows the Centers for […]
Read More
Could markets be facing an ‘everything bubble’? Investors are divided
Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets. Some respite from a four-day sell-off followed Nvidia ‘s earnings release on Wednesday, but its own gains were quickly reversed during Thursday’s trading session as New York-listed stocks lost further ground . Friday saw U.S. stocks rebound […]
Read More
European stocks tick higher; Luxury carmaker Mercedes up 5.7%, on pace for best trading day since 2022
Traders work, as a screen broadcasts a news conference by U.S. Federal Reserve Chair Jerome Powell following the Fed rate announcement, on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., Sept. 17, 2025. Brendan McDermid | Reuters LONDON — European stocks edged higher on Wednesday, with some stocks particularly […]
Read More
European stocks close higher as pharma giants AstraZeneca and GSK notch gains
Stocks listed in Europe closed higher on Monday, as investors monitored the impact of a potential U.S. government shutdown later in the week. The pan-European Stoxx 600 provisionally ended up around 0.34%, with most sectors and major bourses in positive territory. Lufthansa ended the session slightly higher, paring earlier gains, after it said its free […]
Read More
GSK’s Walmsley to step down early as insider Luke Miels named next CEO
Emma Walmsley, chief executive officer of GlaxoSmithKline PLC, listens during a meeting with the Coronavirus Task Force and pharmaceutical executives in the Cabinet Room of the White House in Washington, D.C., U.S. on Monday, March 2, 2020. Kevin Dietsch | Bloomberg | Getty Images GSK’s CEO Emma Walmsley will step down in December and be […]
Read More
Why Trump’s 100% drug tariffs could hit Asia and Europe very differently
Global pharmaceutical stocks sold off on Friday, as markets reacted to news of 100% tariffs on branded and patented drugs imported into the United States, but significant moves lower haven’t been across the board. While Asia Pacific-listed shares in the sector saw notable falls — with some stocks tumbling more than 5% — the reaction […]
Read More